Met Syn Lysine developed new peptide drugs which can be ingested and can reduce hunger of the patient. This makes the insulin secretion of the patient lower and reduces the hunger sensation of the patient.
| Company Name | Met Syn Lysine Ltd. |
| Brand Name | Met Syn Lysine |
| Industries | BioTech Healthcare |
| Year of Establishment | / |
| Founder(s) | Dr. Yarom Cohen M.D |
| No. of Employees | 1-10 |
| Regional Coverage | / |
| Clients | / |
| Stage | / |
| Investor(s) | / |
| Raising Fund | Yes (Jun 2018) |
| Pre-money valuation | / |
| Post-money Valuation | / |
| Fundraising target | / |
| Fundraising History | / |
| Media Explosure | / |
| Company Email | [email protected] |
[dcb id=5586]